Behavioral Intervention Program and Vaginal Cones on SUI
Study Details
Study Description
Brief Summary
This study is a single blind randomized clinical trial to compare the efficacy of a behavioral intervention program versus vaginal cones on Stress Urinary Incontinence (SUI).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
Detailed Description: In this single-blind randomized clinical trial, 60 women aged 25-65 yrs with stress urinary incontinence were randomly divided in two groups by blocked randomization method; behavioral intervention program (n=30) and insertion vaginal device,vaginal cones (n=30). Women in behavioral intervention group were instructed for pelvic floor exercise and bladder control strategies. Other group was allocated to use vaginal cones. They were treated for 12 weeks and followed up every 2 weeks. The subjective changes in severity of SUI were measured using a Detection SUI Severity Questionnaire and leakage index and 3-day urinary dairy. The objective changes were measured by pad test. These two groups were then compared according to the scores of special questionnaires for quality of life, strength of pelvic floor muscles, capability to participate in social activities, severity of urinary incontinence, and the number of involuntary urine passage, taken before, and after 1 and 3 months after finishing interventions. Data analysis will be done through descriptive and perceptive statistical methods by using SPSS.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: behavioural intervention Recieving interventional behavioural program |
Behavioral: behavioural program
interventional behavioural program
Other Names:
|
Experimental: vaginal cone intravaginal device insertion(vaginal cone) |
Device: Iranian version of vaginal cones
intravaginal device(vaginal cone) for promote the pelvic floor exercises
Other Names:
|
Outcome Measures
Primary Outcome Measures
- severity of Stress Urinary Incontinence [three months]
Secondary Outcome Measures
- Quality of life [three months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
symptoms of SUI , at least three episodes of stress incontinence per week
-
Age 25-65
-
body mass index (BMI) ≤ 30 kg/m2
-
physical health
Exclusion Criteria:
-
chronic degenerative diseases affected on muscular and nerve tissues
-
vulvovaginitis, atrophic vaginitis,
-
pregnancy
-
active or recurrent urinary tract infections
-
advanced genital prolepses
-
patients with cardiac pacemakers
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mashhad university of medical science | Mashhad | Iran, Islamic Republic of |
Sponsors and Collaborators
- Mashhad University of Medical Sciences
Investigators
- Study Director: Nahid golmakani, M.Sc., Mashhad university of medical science, faculty of nursing and midwifery, Mashhad, Iran
- Study Chair: Nayereh khadem, M.D., Mashhad university of medical science, Mashhad, Iran
- Principal Investigator: Arezoo Arabipoor, M.Sc., Mashhad university of science, faculty of nursing and midwifery, Mashhad, Iran
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- clinical trial